GlassScriptPhysician profile
Benjamin Y Tu
NPI 1053520361
$21,912.08
in general payments reported to CMS, 2019-2025
59 companies · $3,388 in 2025
The $3,388 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,021 · 2020: $2,174 · 2021: $3,490 · 2022: $3,495 · 2023: $3,729 · 2024: $3,615 · 2025: $3,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,731.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,505.29 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Novo Nordisk INC | $2,337.23 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,887.33 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $1,606.09 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $1,479.75 | 2019-2025 | Spravato |
| Pfizer INC. | $1,111.87 | 2019-2025 | |
| Amgen INC. | $1,051.68 | 2019-2025 | Otezla, Repatha, Repatha |
| Abbott Laboratories | $885.75 | 2019-2025 | Proclaim, Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $840.38 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amarin Pharma, INC. | $638.57 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $494.13 | 2019-2024 | Jardiance, Tradjenta |
| Biohaven Pharmaceutical Holding Company LTD. | $423.83 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $408.99 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Bayer Healthcare Pharmaceuticals INC. | $378.60 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $352.51 | 2019-2023 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $335.67 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $280.06 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $222.29 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $216.97 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $215.47 | 2019-2023 | Belsomra |
| Teva Pharmaceuticals USA, INC. | $210.62 | 2019-2025 | Airduo Digihaler, Austedo Xr |
| Biohaven Pharmaceuticals, INC. | $187.92 | 2021 | |
| Phathom Pharmaceuticals, INC. | $176.83 | 2024 | Voquezna |
| Dexcom, INC. | $150.21 | 2022-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $143.91 | 2020-2025 | Veozah |
| Allergan, INC. | $137.84 | 2019-2020 | |
| Radius Health, INC. | $133.24 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $111.36 | 2019-2024 | |
| Axsome Therapeutics, INC. | $107.17 | 2023-2025 | Auvelity |
| Adlon Therapeutics L.P. | $85.53 | 2021 | |
| Eisai INC. | $81.71 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $80.02 | 2025 | Caplyta |
| Antares Pharma, INC. | $48.37 | 2024 | Xyosted |
| Otsuka America Pharmaceutical, INC. | $37.58 | 2023-2024 | Rexulti |
| Upsher-Smith Laboratories LLC | $36.59 | 2021 | |
| Lundbeck LLC | $32.95 | 2023 | Vyepti |
| Pulmonx Corporation | $31.62 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Seqirus USA INC | $28.75 | 2025 | Flucelvax, Fluad |
| Medtronic Minimed, INC. | $27.28 | 2019-2020 | |
| Ucb, INC. | $26.91 | 2021 | |
| Inspire Medical Systems, INC. | $26.60 | 2024 | Inspire |
| Abiomed | $24.75 | 2023 | Impella |
| Edwards Lifesciences Corporation | $24.23 | 2022 | |
| Corium, LLC | $23.73 | 2023-2024 | Azstarys |
| Medtronic, INC. | $23.36 | 2024 | Inpen Smart Insulin Delivery System |
| Supernus Pharmaceuticals, INC. | $21.73 | 2021 | |
| Verona Pharma, INC. | $21.65 | 2025 | Ohtuvayre |
| Sanofi Pasteur INC. | $21.00 | 2024 | |
| Avanir Pharmaceuticals, INC. | $19.92 | 2021 | |
| Heartflow, INC. | $19.74 | 2025 | |
| Viiv Healthcare Company | $18.20 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $17.44 | 2023 | Opsumit, Uptravi |
| Daiichi Sankyo INC. | $16.93 | 2019 | |
| Redhill Biopharma INC. | $16.08 | 2020 | |
| Noven Therapeutics, LLC | $14.48 | 2024 | Xelstrym, Secuado |
| Bausch Health US, LLC | $13.56 | 2019 | |
| Horizon Therapeutics Plc | $13.49 | 2022 | |
| Currax Pharmaceuticals LLC | $13.34 | 2021 | |
| Gilead Sciences, INC. | $12.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Tu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.